CYP3A Inhibitor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma (NCT05494866) | German Cancer Research Center | 2022-12-07 |
Track CYP3A Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.